UofL RBL Pandemic Preparedness and Response Integrated Research Core
UofL RBL 流行病防范和应对综合研究核心
基本信息
- 批准号:10793921
- 负责人:
- 金额:$ 179.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-18 至 2028-07-31
- 项目状态:未结题
- 来源:
- 关键词:AgingAlcoholic Liver DiseasesAllyAlphavirusAnimal ModelArthritogenicAttentionAutopsyBlood Chemical AnalysisBusinessesCOVID-19Cardiometabolic DiseaseCenters of Research ExcellenceChronicChronic DiseaseClinicalCollaborationsCommunicable DiseasesCommunitiesDataData AnalysesDevelopmentDiseaseDisease OutcomeElderlyEmerging Communicable DiseasesEnsureEnvironmental ExposureEnvironmental ImpactEnvironmental MedicineFundingHealthHematologyImmunologyIn VitroIndustrializationInfectionInvestigationInvestigational DrugsInvestmentsJapanese encephalitis virusLaboratoriesMeasurementMetabolicMetabolic DiseasesMissionModelingNational Institute of Allergy and Infectious DiseaseOutcomeOutcome StudyPathogenesisPathologyPersonsPharmacodynamicsPhysiologicalPositronPositron-Emission TomographyPowassan virusReadinessRecoveryReportingReproducibilityResearchResearch DesignResearch PersonnelRiskSARS-CoV-2 infectionScanningSemliki forest virusService delivery modelServicesSystemTestingToxic Environmental SubstancesToxicant exposureTranslational ResearchUnited States National Institutes of HealthUniversitiesViral PathogenesisVirusVirus DiseasesVulnerable PopulationsWest Nile virusWhole Body PlethysmographyWorkforce DevelopmentX-Ray Computed Tomographychikungunyacostenvironmental toxicologyfuture pandemicglobal environmentgood laboratory practicein vivoin vivo Modelin vivo imaginginfectious disease modelinstrumentinstrumentationmedical countermeasuremouse modeloperationpandemic potentialpandemic preparednesspandemic responsepathogenprogramspulmonary functionresponse
项目摘要
SUMMARY: PANDEMIC PREPAREDNESS AND RESPONSE INTEGRATED RESEARCH SERVICES CORE
The Pandemic Preparedness and Response Integrated Research Services Core (PaPR Core) shall support all
Risk Group 3 (RG3) pathogen studies conducted at the University of Louisville (UofL) Regional Biocontainment
Laboratory (RBL). In alignment with the NIAID Pandemic Preparedness Mission, the PaPR Core shall serve
investigators at UofL, our regional academic and industrial partners, collaborating investigators in the NBL/RBL
network and other investigators who wish to avail of our facilities and expertise. The PaPR Core supports funded
research programs by providing scientific expertise on study design, labor to support execution of both in vitro
and in vivo BSL-3 studies, and data analysis and interpretation services that culminate in issuing a
comprehensive study report to the sponsor investigator. The PaPR Core shall operate on a cost-recovery
business model, with revenue re-invested in core services. The aims of the PaPR Core are to: (1) Support
continuous refinement of RG3 pathogen infection models established at UofL RBL.; (2) Support continuous
refinement of RG3 pathogen infection models established at UofL RBL; (3) Enable investigations on the impact
of aging and chronic metabolic disease on RG3 pathogen infections; and (4) Enable studies on the impact of
environmental toxicant exposure on RG3 pathogen infections.
摘要:大流行病准备和应对综合研究服务核心
流行病防范和应对综合研究服务核心(PaPR核心)将支持所有
在路易斯维尔大学(UofL)区域生物防护进行的风险组3(RG 3)病原体研究
实验室(RBL)。根据NIAID的大流行准备使命,PaPR核心应
UofL的调查人员,我们的区域学术和工业合作伙伴,NBL/RBL的合作调查人员
网络和其他调查人员谁希望利用我们的设施和专业知识。PaPR核心支持资助
通过提供研究设计方面的科学专业知识,支持体外研究和
和体内BSL-3研究,以及数据分析和解释服务,最终发布一份
向申办者研究者提交综合研究报告。PaPR核心应在成本回收的基础上运作
商业模式,收入再投资于核心服务。PaPR核心的目标是:(1)支持
不断改进在UofL RBL建立的RG 3病原体感染模型。(2)支持连续
完善在UofL RBL建立的RG 3病原体感染模型;(3)能够调查对
衰老和慢性代谢疾病对RG 3病原体感染的影响;以及(4)能够研究
环境毒物暴露对RG 3病原体感染的影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KENNETH E PALMER其他文献
KENNETH E PALMER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KENNETH E PALMER', 18)}}的其他基金
UofL RBL Operations, Workforce Development and Pandemic Preparedness Research
伦敦大学 RBL 运营、劳动力发展和流行病防范研究
- 批准号:
10793918 - 财政年份:2023
- 资助金额:
$ 179.3万 - 项目类别:
Upgrading infectious disease research facilities at University of Louisville RBL
升级路易斯维尔大学 RBL 传染病研究设施
- 批准号:
10631406 - 财政年份:2022
- 资助金额:
$ 179.3万 - 项目类别:
Upgrading infectious disease research facilities at University of Louisville RBL
升级路易斯维尔大学 RBL 传染病研究设施
- 批准号:
10394525 - 财政年份:2021
- 资助金额:
$ 179.3万 - 项目类别:
Project 2: PREVENT Preclinical safety and efficacy studies
项目2:预防临床前安全性和有效性研究
- 批准号:
9276592 - 财政年份:2016
- 资助金额:
$ 179.3万 - 项目类别:
Project 2: PREVENT Preclinical safety and efficacy studies
项目2:预防临床前安全性和有效性研究
- 批准号:
8769379 - 财政年份:2014
- 资助金额:
$ 179.3万 - 项目类别:
Griffithsin-based Rectal Microbicides for PREvention of Viral ENTry (PREVENT)
基于 Griffithsin 的直肠杀菌剂用于预防病毒进入(预防)
- 批准号:
8769373 - 财政年份:2014
- 资助金额:
$ 179.3万 - 项目类别:
Griffithsin-based Rectal Microbicides for PREvention of Viral ENTry (PREVENT)
基于 Griffithsin 的直肠杀菌剂用于预防病毒进入(预防)
- 批准号:
9095157 - 财政年份:2014
- 资助金额:
$ 179.3万 - 项目类别:
Griffithsin-based Rectal Microbicides for PREvention of Viral ENTry (PREVENT)
基于 Griffithsin 的直肠杀菌剂用于预防病毒进入(预防)
- 批准号:
8875600 - 财政年份:2014
- 资助金额:
$ 179.3万 - 项目类别:
相似海外基金
Uncovering the Role of Retinoic Acid Receptor Beta in Alcoholic Liver Diseases
揭示视黄酸受体β在酒精性肝病中的作用
- 批准号:
10019450 - 财政年份:2019
- 资助金额:
$ 179.3万 - 项目类别:
Uncovering the Role of Retinoic Acid Receptor Beta in Alcoholic Liver Diseases
揭示视黄酸受体β在酒精性肝病中的作用
- 批准号:
9896234 - 财政年份:2019
- 资助金额:
$ 179.3万 - 项目类别:
Alcoholic Liver Diseases: Damage, Repair and Stem Cell Regeneration
酒精性肝病:损伤、修复和干细胞再生
- 批准号:
7990196 - 财政年份:2010
- 资助金额:
$ 179.3万 - 项目类别:
Alcoholic Liver Diseases: Damage, Repair and Stem Cell Regeneration
酒精性肝病:损伤、修复和干细胞再生
- 批准号:
8299173 - 财政年份:2010
- 资助金额:
$ 179.3万 - 项目类别:
Alcoholic Liver Diseases: Damage, Repair and Stem Cell Regeneration
酒精性肝病:损伤、修复和干细胞再生
- 批准号:
8102173 - 财政年份:2010
- 资助金额:
$ 179.3万 - 项目类别:
Alcoholic Liver Diseases: Damage, Repair and Stem Cell Regeneration
酒精性肝病:损伤、修复和干细胞再生
- 批准号:
8494464 - 财政年份:2010
- 资助金额:
$ 179.3万 - 项目类别:
Alcoholic Liver Diseases: Damage, Repair and Stem Cell Regeneration
酒精性肝病:损伤、修复和干细胞再生
- 批准号:
8693870 - 财政年份:2010
- 资助金额:
$ 179.3万 - 项目类别:
Screening of food components for the prevention of alcoholic liver diseases and their application
预防酒精性肝病的食品成分筛选及其应用
- 批准号:
21500783 - 财政年份:2009
- 资助金额:
$ 179.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Contribution of transforming growth factor-a to thr development of hepatic fibrosis in alcoholic liver diseases
转化生长因子-a对酒精性肝病肝纤维化发展的贡献
- 批准号:
09670560 - 财政年份:1997
- 资助金额:
$ 179.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Immunological mechanism on the generation of alcoholic liver diseases
酒精性肝病发生的免疫学机制
- 批准号:
03670349 - 财政年份:1991
- 资助金额:
$ 179.3万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)














{{item.name}}会员




